EN ▼ 中文
  1. Karin Voit Bak

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Founder, CEO and President of German INUS International Medical Center

    Member of the council of Immune Medical Institute, European Union

    Designer of Double-membrane Target Intervention System for Environmental and Metabolic Toxins

  2. Marco Salafia

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Vice President of German INUS International Medical Center

  3. Dr.Richard Straube

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Professor of University of Bochum, Germany

    Chief Expert of Apheresis, German INUS International Medical Center

  4. Johann Schaeffler

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Chief Physician of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  5. Bernhard Zapp

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Doctor of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  6. Florian Zschacke

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Doctor of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  7. Jutta Babara Anna Pamler

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Doctor of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  8. Iryna Pustynnikava

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Doctor of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  9. Viktar Tsikhanau

    Scientific Consultant of the First International Advisory Committee, Guangdong Research Institute of Target Tumor Intervention and Prevention

    Doctor of German INUS International Medical Center

    German INUS Overseas Consultant to TE-PEMIC Medical

  1. 全球健康联盟东欧主席

    Alla Sokolova

    广东省靶向肿瘤干预与防控研究院科学顾问
  2. 国际肿瘤标志学会主席Univ.Prof.Dr.Dr.George Birkmayer

    广东省靶向肿瘤干预与防控研究院科学顾问
  3. 匈牙利世界胆固酵疫苗发明人Dr.Papp Lehel György

    广东省靶向肿瘤干预与防控研究院科学顾问
  4. 金永宽教授

    William Y. Kim, Assistant Professor of Medicine & Genetics

    广东省靶向肿瘤干预与防控研究院科学顾问
  5. Joe Parkers

    广东省靶向肿瘤干预与防控研究院科学顾问
  6. David Diaz-Sanchez (Chief, clinical research branch, human studies division)

    广东省靶向肿瘤干预与防控研究院科学顾问
  7. Haiyan、James M.Same

    广东省靶向肿瘤干预与防控研究院科学顾问
  8. 广东省靶向肿瘤干预与防控研究院科学顾问
  9. Franco Lugnani(意大利国际冷冻治疗学会荣誉主席

    Carlos Hernández(西班牙泌尿学会主席)

    Ahmed Gouda Elgazzar(埃及Benha大学医学院院长)

    Ahmed Youssef Gad(埃及亚历山大大学医学院,国际冷冻治疗学会副主席)

    Israel Barken(美国加州大学圣地亚哥分校教授,美国前列腺癌基金会主席)

    Ilya Burovik(俄罗斯国家医学研究中心)

学术会议

中国非公立医疗机构协会预防医疗分会筹建专家座谈会(2018)

为深入贯彻预防为主的国家健康发展战略部署,更好的为人民群众提供全方位全周期健康服务,着力推进我国预防医疗卫生事业发展。2018年3月24日下午,中国非公立医疗机构协会预防医疗分会筹建专家座谈会在北京召开。中国非公立医疗机构协会相关领导,预防医疗产业领域的专家学者及企业代表出席了会议。会议内容围绕分会发起及筹建工作背景、分会工作职能、组成人员及筹备成立工作计划等事项展开了深入探讨,与会人员分享了各自的筹建分会经验,提出了工作意见和建议,讨论形成了广泛和重要共识。

北京预防医疗研讨会议(2018)

2018年3月24日上午,北京预防医疗研讨会议在北京举行。本次会议由中国医疗保健国际交流促进会分子保健分会、全国卫生产业企业管理协会预防医疗分会主办,广东省靶向肿瘤干预与防控研究院、北京国贸国际医学中心承办,会议主持由中国医疗保健国际交流促进会分子保健分会主任委员、全国卫生产业企业管理协会预防医疗分会副会长兼秘书长、广东省靶向肿瘤干预与防控研究院院长、南方医科大学教授张积仁教授担任。会议围绕预防医疗学科发展方向、预防医疗学科体系建设等话题展开了深入探讨,形成了一系列重要共识。

第二届预防医疗国际研讨会(2017)

2017年9月8日,第二届国际预防医疗联盟大会暨腾湃北京国贸国际医学中心开业典礼在北京举行。本次大会由中华预防医学会、清华大学社会科学学院健康产业与管理研究中心、清华大学一带一路战略研究院、中国社会福利基金会主办,腾湃健康产业集团承办,以“发展预防医疗体系,推动健康中国建设”为主题。卫生与计划生育委员会相关领导,全国卫生产业企业管理协会领导,健康医疗产业领域的企业代表以及国内外预防医疗领域的专家学者六百余人参加了会议。会议围绕预防医疗发展中的制度设计、学术研究的最新进展、相关产业的最新动态、TE-PEMIC慢病绿色预防医疗体系的技术发展等话题展开了深入探讨,形成了一系列重要共识。并与会上宣布,由腾湃健康产业集团投资成立的首都第一家专业预防医疗医院——北京腾湃国贸国际医学中心开业。

TE-PEMIC 慢病绿色预防医疗体系专家共识(2015)

张积仁教授带领的科研团队整合了国际先进的分子医学、环境医学、功能医学、细胞免疫及预防医学技术,建立了第一个预防医疗技术平台,提出分子保健的理念,并建立了绿色慢病风险干预技术体系。 张积仁教授团队通过研究认为:人体微循环中不稳定的蛋白质(Proteins Variation or heteromorphosis)、体内暴露和残留的环境毒素(Environmentaltoxins,如重金属、农药、有毒化学物质)、蓄积的代谢毒素和分子突变物质(metabolic wastes and molucular mutation)、免疫抑制因子((immunosuppressive factors)、慢性炎性因子(chronic inflammatory factors)是人类慢性疾病和衰老的主要因素。靶向排出和干预(targete valuation and intervention)体内这些致病因子是慢病靶向预防技术体系需要解决的关键问题,也是健康和预防医疗技术的发展方向。因此,他们将研究建立的风险评估和干预分子标准定名为TE-PEMIC。 2015年11月21日,在第一届全球预防医疗联盟大会暨第二届全国分子保健与预防医疗大会上,张积仁作为大会主席就TE-PEMIC慢病绿色预防技术体系进行了系统的阐述,并得到来自美国、德国、马来西亚、印度、泰国等国家和地区的200多位与会专家和学者的一致认同。

成立中国医促会分子保健预防医疗专业委员会——《预防医疗国际化面对的挑战》(2015)

经中国医疗保健国际交流促进会批准,中国医促会分子保健分会于2015年11月20-21日第一届全球预防医疗联盟大会暨第二届全国分子保健与预防医疗大会期间,成立中国医促会分子保健预防医疗专业委员会,共同发展国内的预防医疗事业。 中国医促会分子保健预防医疗专业委员会于狮子湖成立,也标志着狮子湖作为分子保健理论实践基地的成立。会上提出分子保健预防医学新概念,将践行分子养护、细胞功能调理、超早期预警、风险病因干预的养生、延寿。此理论体系将于狮子湖得到进一步的推广,将加速推动国家一二预防体系的建立。

第一届全球预防医疗联盟大会暨第二届全国分子保健与预防医疗大会(2015)

2015年11月20-21日,以“让生命远离疾病”为主题的第一届全球预防医疗联盟大会暨第二届全国分子保健与预防医疗大会在广东狮子湖国际医疗旅游度假区盛大举办。来自中国、美国、德国、马来西亚、印度、泰国等国家和地区的二百多位与会专家、学者在会上达成大会共识:实现“健康中国”战略的关键,是要抓紧建立慢病预防技术体系,即要在慢病风险因子的靶向干预和排除技术上取得突破性的进展。 TE-PEMIC慢病预防技术体系,即通过健康评估和分子、蛋白、细胞等的检测,建立健康预警机制,靶向排除(Target Elimination)人体的细胞生长内环境中变性及不稳定蛋白(Protien: Unstable or Intrinsically Disordered Proteins)、体内残留的外源性环境毒素(Enviromental Toxins)、蓄积的内源性代谢毒素(Metabolic Waste and Metabolic Accumulated Wastes)、免疫抑制因子(Immunosuppressive Factor)和慢性炎性因子(Chronic Inflammatory Factor),并针对上述风险因素,以代谢平衡为目的加以营养干预,以控制长期风险为目的进行个体化生活方式管理和干预。该体系整合了环境医学、功能医学、分子医学、细胞免疫及生物医学技术,已在大会中得到二百多位与会专家、学者的共识。

Overview of the Research Institute

As a non-profit first-level scientific research institution in Guangdong province approved and established by the Department of Civil Affairs of Guangdong Province, Guangdong Research Institute of Target Tumor Intervention and Prevention aims to build up a transformational medical platform and technical service system which can provide the Chinese people with tumor prevention, screening, intervention as well as health management and national tumor third-level prevention and control system with medical decisions and technical services. Focused on the technological development of the international health industry of preventive medicine, the institute works closely with scientific research institutions home and abroad and colleges and universities so as to enable the comprehensive development of the integration of industry, university and research. The research institute co-built the Research and Management Center for Health Industry of Tsinghua University with Tsinghua University School of Social Sciences, and co-founded the Environmental Carcinogen Intervention and Prevention Research Laboratory with the International Target Therapy Society. Under it is Lion Lake International Medical Center affiliated to Guangdong Research Institute of Target Tumor Intervention and Prevention; Beijing China World Trade Center International Medical Center affiliated to Guangdong Research Institute of Target Tumor Intervention and Prevention; Thousand-island Lake International Medical Center affiliated to Guangdong Research Institute of Target Tumor Intervention and Prevention; Shanghai TE-PEMIC Biomedical Research Institute affiliated to Guangdong Research Institute of Target Tumor Intervention and Prevention; Qingyuan Examination Center of Molecular Medicine affiliated to Guangdong Research Institute of Target Tumor Intervention and Prevention; The institute has established wide cooperative ties with scientific research and technical service institutions including Southern Medical University, the Biology Institute of the Chinese Academy of Sciences, Guangzhou Medical University, BGI, Kingmed Diagnostics , Microdiag medical Examination and German INUS International Medical Center. It set up the first specimen bank and database of heavy metal intervention of human body in China, and the specimen bank and database of intervention of anti-aging metabolic toxins and meanwhile initiated the national multi-disciplinary metabonomics analysis of centenarians and the scientific research collaboration project of the detection and analysis of heavy metal chelates in human body. There are around one hundred staff in the heavy metal carcinogenic intervention and control research of the institute, including around 10 overseas experts, around 20 domestic experts and around 60 staff with doctor and master degrees who participate in the research of environmental carcinogens prevention and control. Currently, 1000 successful individual intervention featuring heaving metals have been completed. Over 60 patented technologies have been established and the First Global Preventive Medical Union Convention was successfully held . TE-PEMIC Green Preventive Medicine System for Chronic Disease was reached consensus on and was reported several times by domestic and overseas media.

Electronic Journal